Positive antibody tests not proof of immunity

Gangakhedkar ’s statement came during a webinar organized by the National Cancer Grid, in a presentation on the evolution of the testing protocol of the government for the virus outbreak.
Source: The Economic Times - Category: Consumer Health News Source Type: news

Related Links:

The government hopes it will no longer be necessary to shield – but tell that to those people in England who are at highest riskOn Monday, a major change to lockdown will begin: people with underlying health conditions in England who have been shielding since March will be able to meet up outside in groups of up to six people, while those who live alone will be allowed to form a “support bubble” with one other household. The government hassaid high-risk people will no longer need to shield at all from 1 August.This should be a moment of relief. Shielders have in many ways become the forgotten millions of ...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Disability Coronavirus outbreak Infectious diseases Science Older people Benefits Cancer Health Diabetes UK news Source Type: news
V Krishnapriya, Puneet Rathore, Sanjeev Kumar, Shweta, Alice Thankachan, Nengneivah Haokip, Saurabh Vig, Sushma BhatnagarIndian Journal of Palliative Care 2020 26(5):173-175 The COVID-19 outbreak is an unexpected challenge to all areas of health-care delivery, including cancer centers. The novel coronavirus is known to affect individuals in all age groups, especially patients with multiple comorbidities. A nationwide lockdown has restricted the routine patient care, with health-care services focusing mainly on emergency services and COVID patient management. These restrictions in health services may delay the treatments o...
Source: Indian Journal of Palliative Care - Category: Palliative Care Authors: Source Type: research
Recently, Radiotherapy and Oncology published an article entitled “Workflow and Protection Procedures During the Coronavirus Disease 2019 (COVID-19) Outbreak: Experience of the Hubei Cancer Hospital in Wuhan, China.” describing multiple measures for patient and staff COVID-19 protection and prevention at the Hubei Cancer Hospital” [1].
Source: Radiotherapy and Oncology - Category: Radiology Authors: Source Type: research
Seema Mishra, Swagata Biswas, Sushma BhatnagarIndian Journal of Palliative Care 2020 26(5):130-141 World is facing a pandemic recently due to the outbreak of COVID-19 infection. Cancer has been identified as one of the major comorbidities which cause more severe disease due to COVID-19 infection. Moreover, there are several resource limitations and restrictions to avail the standard oncological health facilities due to robust measures taken for infection control. In this situation, palliative care in cancer patients deserves special attention. Their symptom management, psychological, social, cultural needs tremendously in...
Source: Indian Journal of Palliative Care - Category: Palliative Care Authors: Source Type: research
The handling of those highly vulnerable to coronavirus speaks volumes about attitudes towards chronic illness and disabilityFor more than 2 million people in England, the effects of the pandemic have beenespecially punishing– forcing them to keep a distance even from others in their household. Those who have been judged clinically extremely vulnerable, including transplant recipients and those undergoing some cancer treatments, have spent months shut away. Now, with remarkably little scrutiny, they are beingurged out of shielding.From 6 July, they willno longer be expected to distance themselves from those they live ...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus outbreak Infectious diseases Science Medical research Health Disability Children Schools Education Society Politics Source Type: news
Gangakhedkar ’s statement came during a webinar organized by the National Cancer Grid, in a presentation on the evolution of the testing protocol of the government for the virus outbreak. Gangakhedar is one of the key members of ICMR driving India’s Covid-19 strategy.
Source: The Economic Times - Category: Consumer Health News Source Type: news
In late January 2020, Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2) was reported as an outbreak in Wuhan, China. Within 2 months it became a global pandemic. Patients with cancer are at highest risk for both contracting and suffering complications of its resultant disease, Coronavirus 19 (COVID-19). Healthcare systems across the world had to adapt quickly to mitigate this risk, while continuing to provide potentially lifesaving treatment to patients. Bringing care to the home through the use of telehealth, home based chemotherapy, and remote patient monitoring technologies can help minimize risk to the patie...
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
CONCLUSIONS: Our findings suggest that PET/CT is a sensitive modality to hypothesize SARS-CoV-2 pneumonia in patients with cancer, even when asymptomatic. More data are needed to verify the correlation among immune response to SARS-CoV-2 infection, clinical evolution, and PET results. Under the strict safety measures implemented at the PET center, the number of potentially SARS-CoV-2-positive patients undergoing PET/CT was very low (1.6%), and no staff member has been diagnosed with infection as of April 30, 2020. PMID: 32567505 [PubMed - as supplied by publisher]
Source: Tumori - Category: Cancer & Oncology Tags: Tumori Source Type: research
Fairooz P Manjandavida, Santosh G Honavar, Usha Kim, Usha Singh, Vikas Menon, Sima Das, Swathi Kaliki, Mahesh Shanmugam Palanivelu, Vikas Khetan, Parag K Shah, Pukhraj Rishi, Kaustubh Mulay, Arpan Gandhi, BM Vadhiraja, Vijay Anand Reddy, Sunil Bhat, Vasudha RaoIndian Journal of Ophthalmology 2020 68(7):1281-1291 The outbreak of rapidly spreading COVID-19 pandemic in December 2019 has witnessed a major transformation in the health care system worldwide. This has led to the re-organization of the specialty services for the effective utilization of available resources and ensuring the safety of patients and healthcare worker...
Source: Indian Journal of Ophthalmology - Category: Opthalmology Authors: Source Type: research
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today ’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Today, we are pleased to welcome a guest post from Chris Arendt, Ph.D., a leader of Takeda’s oncology team to discuss how the company is ensuring cancer research and medicines continue to benefit patients in the age of COVID-19.“The new normal” has been used to describe the challenging and dy...
Source: The Catalyst - Category: Pharmaceuticals Authors: Tags: PhRMA Member Company Cancer Coronavirus Source Type: news
More News: Cancer | Cancer & Oncology | Government | Health | Outbreaks